Young Adult With Acute Lymphoblastic Leukemia (ALL) : a Multicentric Protocol. GRAALL [Group for Research on Adult Acute Lymphoblastic Leukemia] 2005 : T ALL or B ALL Non Ph GRAALL 2005 R : B ALL Non Ph CD20+ GRAAPH 2005 : ALL Ph

Trial Profile

Young Adult With Acute Lymphoblastic Leukemia (ALL) : a Multicentric Protocol. GRAALL [Group for Research on Adult Acute Lymphoblastic Leukemia] 2005 : T ALL or B ALL Non Ph GRAALL 2005 R : B ALL Non Ph CD20+ GRAAPH 2005 : ALL Ph

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Jun 2018

At a glance

  • Drugs Rituximab (Primary) ; Antineoplastics; Cyclophosphamide; Imatinib
  • Indications Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2018 Results published in the Journal of Clinical Oncology
    • 06 Dec 2016 Results of the prophylactic replacement strategy (n=787) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
    • 06 Dec 2016 Results of a retrospective analysis (n=787) assessing the occurrence of Bacterial infections during induction treatment, presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top